Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119609 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Pietro Salvatore Carollo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies, University of Palermo, 90128 Palermo, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione per la Ricerca sulla Fibrosi Cistica, European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 "HEAL ITALIA", European Union-NextGenerationEU.
Abstract (Originalsprache)
Cystic Fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the CFTR gene, coding for the CFTR chloride channel. About 10% of the CFTR gene mutations are “stop” mutations that generate a premature termination codon (PTC), thus synthesizing a truncated CFTR protein. A way to bypass PTC relies on ribosome readthrough, which is the ribosome’s capacity to skip a PTC, thus generating a full-length protein. “TRIDs” are molecules exerting ribosome readthrough; for some, the mechanism of action is still under debate. We investigate a possible mechanism of action (MOA) by which our recently synthesized TRIDs, namely NV848, NV914, and NV930, could exert their readthrough activity by in silico analysis and in vitro studies. Our results suggest a likely inhibition of FTSJ1, a tryptophan tRNA-specific 2′-O-methyltransferase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies, University of Palermo, 90128 Palermo, Italy.
ORCID-Profile: Marco Tutone, Giulia Culletta, Ivana Pibiri, Aldo Di Leonardo, Maria Grazia Zizzo, Raffaella Melfi, Andrea Pace, Laura Lentini
Förderung
- Fondazione per la Ricerca sulla Fibrosi Cistica
- European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 "HEAL ITALIA"
- European Union-NextGenerationEU
- Italian Cystic Fibrosis Research Foundation
Zitieren
APA
Carollo, P. S., Tutone, M., Culletta, G., Fiduccia, I., Corrao, F., Pibiri, I., Di Leonardo, A., Zizzo, M. G., Melfi, R., Pace, A., Almerico, A. M., & Lentini, L. (2023). Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119609
Vancouver
Carollo PS, Tutone M, Culletta G, Fiduccia I, Corrao F, Pibiri I, et al. Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119609
BibTeX
@article{Carollo2023,
author = {Carollo, Pietro Salvatore and Tutone, Marco and Culletta, Giulia and Fiduccia, Ignazio and Corrao, Federica and Pibiri, Ivana and Di Leonardo, Aldo and Zizzo, Maria Grazia and Melfi, Raffaella and Pace, Andrea and Almerico, Anna Maria and Lentini, Laura},
title = {Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119609}
}
EUVIMED